BNP Paribas Arbitrage SA increased its holdings in shares of Phibro Animal Health Corp (NASDAQ:PAHC) by 69.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,076 shares of the company’s stock after purchasing an additional 4,143 shares during the period. BNP Paribas Arbitrage SA’s holdings in Phibro Animal Health were worth $373,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Alps Advisors Inc. lifted its holdings in shares of Phibro Animal Health by 0.3% in the second quarter. Alps Advisors Inc. now owns 17,541 shares of the company’s stock valued at $650,000 after purchasing an additional 46 shares in the last quarter. Arizona State Retirement System increased its position in shares of Phibro Animal Health by 1.0% during the second quarter. Arizona State Retirement System now owns 9,800 shares of the company’s stock valued at $363,000 after acquiring an additional 100 shares during the last quarter. Louisiana State Employees Retirement System increased its position in shares of Phibro Animal Health by 1.3% during the second quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock valued at $282,000 after acquiring an additional 100 shares during the last quarter. Nationwide Fund Advisors increased its position in shares of Phibro Animal Health by 1.0% during the second quarter. Nationwide Fund Advisors now owns 10,866 shares of the company’s stock valued at $403,000 after acquiring an additional 110 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan increased its position in shares of Phibro Animal Health by 3.6% during the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after acquiring an additional 150 shares during the last quarter. 48.42% of the stock is owned by institutional investors and hedge funds.
PAHC has been the subject of a number of research analyst reports. Piper Jaffray Companies set a $41.00 price target on Phibro Animal Health and gave the company a “buy” rating in a research report on Friday, October 6th. Zacks Investment Research raised Phibro Animal Health from a “hold” rating to a “buy” rating and set a $41.00 target price for the company in a research report on Tuesday, October 31st. ValuEngine downgraded Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Thursday, November 9th. Finally, BidaskClub cut Phibro Animal Health from a “hold” rating to a “sell” rating in a research report on Saturday, December 2nd. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $38.25.
Phibro Animal Health Corp (NASDAQ PAHC) traded up $0.80 during trading hours on Tuesday, reaching $34.30. The company had a trading volume of 129,572 shares, compared to its average volume of 100,150. The company has a quick ratio of 1.85, a current ratio of 3.26 and a debt-to-equity ratio of 1.91. Phibro Animal Health Corp has a 12 month low of $26.10 and a 12 month high of $40.25. The company has a market capitalization of $1,360.00, a price-to-earnings ratio of 20.18, a price-to-earnings-growth ratio of 3.93 and a beta of 1.27.
Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Monday, November 6th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.37 by $0.01. Phibro Animal Health had a return on equity of 42.75% and a net margin of 8.87%. The firm had revenue of $193.40 million during the quarter, compared to analyst estimates of $189.89 million. During the same quarter in the previous year, the company posted $0.36 earnings per share. The company’s revenue was up 2.9% compared to the same quarter last year. equities analysts predict that Phibro Animal Health Corp will post 1.57 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th were paid a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date of this dividend was Tuesday, December 5th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 23.53%.
COPYRIGHT VIOLATION NOTICE: “Phibro Animal Health Corp (NASDAQ:PAHC) Shares Bought by BNP Paribas Arbitrage SA” was first reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://www.truebluetribune.com/2018/01/03/bnp-paribas-arbitrage-sa-has-373000-holdings-in-phibro-animal-health-corp-pahc.html.
About Phibro Animal Health
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.